Kansas City, MO, United States of America

Mark S Williams

This inventor holds 3 USPTO granted patents. Top assignee: Carderm Capital L.p.. Active years: 1994-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark S Williams. Retrieved from https://idiyas.com/inventor/mark-s-williams-71s8v9gy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 226(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Mark S. Williams

Introduction

Mark S. Williams is an accomplished inventor based in Kansas City, MO. He has made significant contributions to the field of pharmaceuticals, particularly with his work on diltiazem formulations. With a total of three patents to his name, Williams has demonstrated a commitment to advancing medical treatments.

Latest Patents

One of his notable inventions is a diltiazem formulation designed for once-a-day administration. This innovative formulation contains a blend of diltiazem beads that have two differing dissolution profiles, enhancing the effectiveness and convenience of the medication. This patent reflects Williams' dedication to improving patient care through innovative drug delivery systems.

Career Highlights

Williams is currently associated with Carderm Capital L.P., where he continues to develop and refine his inventions. His work in the pharmaceutical industry has positioned him as a key player in the development of effective medication solutions.

Collaborations

Throughout his career, Williams has collaborated with talented individuals such as Dennis L. Hendrickson and Dan C. Dimmitt. These partnerships have contributed to the success of his projects and the advancement of his inventions.

Conclusion

Mark S. Williams is a notable inventor whose work in diltiazem formulations showcases his innovative spirit and dedication to improving healthcare. His contributions to the pharmaceutical industry are commendable and reflect his commitment to enhancing patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…